# Eric Meizlish

> Eric Meizlish is the CEO of Cardiosense, a Chicago digital health company building AI-enabled, non-invasive cardiac monitoring. A Yale-trained investor turned healthcare operator, he co-founded the clinical analytics firm Lumere (sold to GHX), ran the life-sciences procurement platform Prendio-BioProcure, and started his career investing in tech and media at Citadel. He took the Cardiosense top job in September 2025 to scale the company's CardioTag sensor, which predicts pressures and volumes inside the heart without an implant.

- **Role:** Chief Executive Officer at Cardiosense
- **Organizations:** Cardiosense, Prendio-BioProcure, Lumere, GHX, Citadel, Chicago Giving Circle
- **Nationality:** American
- **Education:** BA, Economics and Mathematics, Yale University
- **Known for:** Co-founded Lumere and led it through acquisition by GHX, Served on the GHX global leadership team as SVP of Strategy and Corporate Development, Led Prendio-BioProcure as CEO

## Career timeline

- **early career** — Investor at Citadel covering publicly traded Technology, Media and Telecommunications companies
- **before Citadel** — Undergraduate intern at the Yale University Investments Office
- **2010s** — Co-founded Lumere (formerly Procured Health), a clinical evidence and analytics company; served as President and Chief Strategy Officer
- **2020** — Lumere acquired by Global Healthcare Exchange (GHX); Meizlish becomes SVP of Strategy and Corporate Development on the GHX global leadership team
- **2024-01** — Appointed CEO of Prendio-BioProcure, a cloud eProcurement platform for life sciences
- **2025-09** — Appointed CEO of Cardiosense, succeeding co-founder Amit Gupta (who became Chief Strategy Officer)

## Achievements

- Co-founded Lumere and led it through acquisition by GHX
- Served on the GHX global leadership team as SVP of Strategy and Corporate Development
- Led Prendio-BioProcure as CEO
- Appointed CEO of Cardiosense to scale its FDA-cleared CardioTag platform
- Board member and advisor to several growth-stage healthcare technology businesses

## Latest updates

- **2025-09** — Named CEO of Cardiosense, succeeding co-founder Amit Gupta who moved to Chief Strategy Officer.
- **2025-07** — Cardiosense received FDA 510(k) clearance for its CardioTag sensor for non-invasive cardiac function monitoring.

## Links

- Website: https://cardiosense.com
- LinkedIn: https://www.linkedin.com/in/ericmeizlish/
- Twitter/X: https://twitter.com/EricMeizlish

---

Profile page: https://yespress.io/eric-meizlish
Published by YesPress — https://yespress.io
Last updated: 2026-06-12